# OPFOLDA

NDC: 71904-300
Generic name: miglustat
Labeler / Manufacturer: AMICUS THERAPEUTICS US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20231011

FDA application: NDA215211

## Active ingredients

- MIGLUSTAT: 65 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71904-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71904-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7c38298-37db-5a80-e053-2995a90aee40